DJ Vertex Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ slid 1.06% to $480.25 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.79% to 7,515.34 and Dow Jones Industrial Average falling 0.26% to 52,498.64.
This was the stock's fifth consecutive day of losses.
Vertex Pharmaceuticals Inc. closed 10.01% short of its 52-week high of $533.67, which the company achieved on July 7th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as AbbVie Inc. $(ABBV)$ fell 0.03% to $248.00, Krystal Biotech Inc. (KRYS) fell 0.65% to $363.44, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ fell 3.73% to $6.71.
Data source: Dow Jones Market Data, FactSet. Data compiled July 13, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
July 13, 2026 16:37 ET (20:37 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments